Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 97
Filtrar
1.
Curr Oncol ; 26(1): e115-e118, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30853818

RESUMEN

Nivolumab, an anti-PD-1 antibody, is now considered an important therapeutic agent in several advanced malignancies. However, immune-related adverse events such as endocrinopathies have been reported with its use. Thyroid disorder and isolated adrenocorticotropic hormone deficiency have frequently been reported as nivolumab-induced immune-related adverse events. Another endocrinopathy is nivolumab-induced type 1 diabetes mellitus (t1dm), described as diabetes mellitus with rapid onset and complete insulin insufficiency, at times leading to fulminant t1dm. We report the case of a 68-year-old woman who developed pancreatic islet-related autoantibody-negative t1dm, possibly induced by nivolumab, under continuous glucocorticoid administration. She was treated with nivolumab for advanced malignant melanoma, concomitant with 10 mg prednisolone daily for thrombophlebitis tapered to 5 mg after 13 courses of nivolumab therapy. At approximately the 27th course of nivolumab therapy, she showed elevated plasma glucose levels despite preserved insulin secretion. A month later, she developed diabetic ketoacidosis. Her insulin secretion decreased and finally was exhausted. She was diagnosed with acute-onset rather than fulminant t1dm because of a rapidly progressive course to diabetic ketoacidosis during just more than 1 week. She is currently receiving insulin replacement. There has been no recurrence of the melanoma. Thus, nivolumab might induce autoimmune diabetes mellitus, with patients having t1dm-sensitive human leucocyte antigen being more susceptible even when receiving glucocorticoids. Physicians should be aware that nivolumab could potentially induce t1dm as a critical immune-related adverse event.


Asunto(s)
Melanoma/inducido químicamente , Nivolumab/efectos adversos , Anciano , Diabetes Mellitus Tipo 1/inducido químicamente , Femenino , Humanos
2.
Plant Biol (Stuttg) ; 17(2): 558-66, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25270225

RESUMEN

The identification of pollen plays an important role in ecology, palaeo-climatology, honey quality control and other areas. Currently, expert knowledge and reference collections are essential to identify pollen origin through light microscopy. Pollen identification through molecular sequencing and DNA barcoding has been proposed as an alternative approach, but the assessment of mixed pollen samples originating from multiple plant species is still a tedious and error-prone task. Next-generation sequencing has been proposed to avoid this hindrance. In this study we assessed mixed pollen probes through next-generation sequencing of amplicons from the highly variable, species-specific internal transcribed spacer 2 region of nuclear ribosomal DNA. Further, we developed a bioinformatic workflow to analyse these high-throughput data with a newly created reference database. To evaluate the feasibility, we compared results from classical identification based on light microscopy from the same samples with our sequencing results. We assessed in total 16 mixed pollen samples, 14 originated from honeybee colonies and two from solitary bee nests. The sequencing technique resulted in higher taxon richness (deeper assignments and more identified taxa) compared to light microscopy. Abundance estimations from sequencing data were significantly correlated with counted abundances through light microscopy. Simulation analyses of taxon specificity and sensitivity indicate that 96% of taxa present in the database are correctly identifiable at the genus level and 70% at the species level. Next-generation sequencing thus presents a useful and efficient workflow to identify pollen at the genus and species level without requiring specialised palynological expert knowledge.


Asunto(s)
Código de Barras del ADN Taxonómico/métodos , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Polen/clasificación , Polen/genética , Animales , Abejas , Bases de Datos Genéticas , Alemania , Flujo de Trabajo
3.
J Clin Pharm Ther ; 39(4): 361-7, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24661251

RESUMEN

WHAT IS KNOWN AND OBJECTIVE: The implementation of appropriate epidemiological methodology using medical information databases (MIDs) to evaluate the effects of regulatory actions has been highly anticipated. To assess scientific methods for active pharmacovigilance using MIDs, we conducted a quantitative assessment of the impact of two regulatory actions by the Japanese government: (i) restriction of use of oseltamivir in teenagers in March 2007 and (ii) caution against the co-administration of omeprazole (OPZ) with clopidogrel (CPG) in April 2010. METHODS: Data were obtained from four hub hospitals in Japan. We measured the seasonal proportion of patients prescribed oseltamivir to those prescribed neuraminidase inhibitors for the 2002/2003 to 2010/2011 seasons. The monthly proportion of patients co-administered OPZ and CPG (OPZ+CPG) to those prescribed CPG was measured from May 2009 to April 2011. We evaluated the changes observed with implementation of the regulatory actions. To estimate the impact of the actions, we conducted segmented regression analysis using interrupted time series data. The impact was assessed by two parameter estimates of the regression model: the change in level for short-term effects and change in trend for long-term effects. RESULTS AND DISCUSSION: The use of oseltamivir in the target 10-19 years age group showed a significant and large decline (63·16%) immediately after the intervention (P = 0·0008). No change was observed in OPZ+CPG, although there was a relative inhibitory trend for OPZ+CPG compared with co-administration of lansoprazole or rabeprazole with CPG as the control group. When restricted to new users of CPG, the stratified results were consistent with the overall results. WHAT IS NEW AND CONCLUSION: The current analysis demonstrates the effectiveness of two regulatory actions. The results of the current study indicate that MID research can contribute to assessing and improving pharmacovigilance activities.


Asunto(s)
Control de Medicamentos y Narcóticos , Omeprazol/uso terapéutico , Oseltamivir/uso terapéutico , Ticlopidina/análogos & derivados , Adolescente , Factores de Edad , Antivirales/administración & dosificación , Antivirales/uso terapéutico , Niño , Clopidogrel , Bases de Datos Factuales/estadística & datos numéricos , Interacciones Farmacológicas , Humanos , Análisis de Series de Tiempo Interrumpido , Japón , Omeprazol/administración & dosificación , Oseltamivir/administración & dosificación , Farmacovigilancia , Inhibidores de Agregación Plaquetaria/administración & dosificación , Inhibidores de Agregación Plaquetaria/uso terapéutico , Pautas de la Práctica en Medicina/estadística & datos numéricos , Inhibidores de la Bomba de Protones/administración & dosificación , Inhibidores de la Bomba de Protones/uso terapéutico , Análisis de Regresión , Ticlopidina/administración & dosificación , Ticlopidina/uso terapéutico , Adulto Joven
4.
Appl Clin Inform ; 4(1): 37-52, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23650486

RESUMEN

BACKGROUND: Most patients cannot remember their entire medication regimen and occasionally forget to take their medication. OBJECTIVES: The objective of the study was to design, develop, and demonstrate the feasibility of a new type of medication self-management system using smartphones with real-time medication monitoring. METHODS: We designed and developed a smartphone-based medication self-management system (SMSS) based on interviews of 116 patients. The system offered patients two main functions by means of smartphones: (1) storage and provision of an accurate, portable medication history and medication-taking records of patients; and (2) provision of a reminder to take medication only when the patient has forgotten to take his/her medication. These functions were realized by two data input methods: (a) reading of prescription data represented in two-dimensional barcodes using the smartphone camera and getting the photographic images of the pills; and (b) real-time medication monitoring by novel user-friendly wireless pillboxes. RESULTS: Interviews suggested that a pocket-sized pillbox was demanded to support patient's medication-taking outside the home and pillboxes for home use should be adaptable to the different means of pillbox storage. In accordance with the result, we designed and developed SMSS. Ten patients participated in the feasibility study. In 17 out of 47 cases (36.2%), patients took their medication upon being presented with reminders by the system. Correct medication-taking occurrence was improved using this system. CONCLUSIONS: The SMSS is acceptable to patients and has the advantage of supporting ubiquitous medication self-management using a smartphone. We believe that the proposed system is feasible and provides an innovative solution to encourage medication self-management.


Asunto(s)
Teléfono Celular , Monitoreo de Drogas/instrumentación , Cumplimiento de la Medicación , Aplicaciones Móviles , Sistemas Recordatorios/instrumentación , Adulto , Anciano , Anciano de 80 o más Años , Esquema de Medicación , Monitoreo de Drogas/métodos , Almacenaje de Medicamentos , Estudios de Factibilidad , Femenino , Humanos , Masculino , Cumplimiento de la Medicación/psicología , Persona de Mediana Edad , Autoinforme , Factores de Tiempo , Tecnología Inalámbrica
5.
Methods Inf Med ; 52(1): 51-61, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23223786

RESUMEN

BACKGROUND: One of the barriers for the effective use of computerized health-care related text is the ambiguity of abbreviations. To date, the task of disambiguating abbreviations has been treated as a classification task based on surrounding words. Application of this framework for languages that have no word boundaries requires pre-processing to segment a sentence into separate word sequences. While the segmentation processing is often a source of problem, it is unknown whether word information is really requisite for abbreviation expansion. OBJECTIVES: The present study examined and compared abbreviation expansion methods with and without the incorporation of word information as a preliminary study. METHODS: We implemented two abbreviation expansion methods: 1) a morpheme-based method that relied on word information and therefore required pre-processing, and 2) a character-based method that relied on simple character information. We compared the expansion accuracies for these two methods using eight medical abbreviations. Experimental data were automatically built as a pseudo-annotated corpus using the Internet. RESULTS: As a result of the experiment, accuracies for the character-based method were from 0.890 to 0.942 while accuracies for the morpheme-based method were from 0.796 to 0.932. The character-based method significantly outperformed the morpheme-based method for three of the eight abbreviations (p < 0.05). For the remaining five abbreviations, no significant differences were found between the two methods. CONCLUSIONS: Character information may be a good alternative in terms of simplicity to morphological information for abbreviation expansion in English medical abbreviations appeared in Japanese texts on the Internet.


Asunto(s)
Abreviaturas como Asunto , Inteligencia Artificial , Comparación Transcultural , Registros Electrónicos de Salud , Procesamiento de Lenguaje Natural , Algoritmos , Humanos , Almacenamiento y Recuperación de la Información , Japón
6.
Methods Inf Med ; 51(3): 221-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-21431245

RESUMEN

OBJECTIVES: In medical institutions, unauthorized access points and terminals obstruct the stable operation of a large-scale wireless local area network (LAN) system. By establishing a real-time monitoring method to detect such unauthorized wireless devices, we can improve the efficiency of security management. METHODS: We detected unauthorized wireless devices by using a centralized wireless LAN system and a location detection system at 370 access points at the University of Tokyo Hospital. By storing the detected radio signal strength and location information in a database, we evaluated the risk level from the detection history. We also evaluated the location detection performance in our hospital ward using Wi-Fi tags. RESULTS: The presence of electric waves outside the hospital and those emitted from portable game machines with wireless communication capability was confirmed from the detection result. The location detection performance showed an error margin of approximately 4 m in detection accuracy and approximately 5% in false detection. Therefore, it was effective to consider the radio signal strength as both an index of likelihood at the detection location and an index for the level of risk. CONCLUSIONS: We determined the location of wireless devices with high accuracy by filtering the detection results on the basis of radio signal strength and detection history. Results of this study showed that it would be effective to use the developed location database containing radio signal strength and detection history for security management of wireless LAN systems and more general-purpose location detection applications.


Asunto(s)
Seguridad Computacional/instrumentación , Confidencialidad , Redes de Área Local/instrumentación , Tecnología Inalámbrica/instrumentación , Radiación Electromagnética , Humanos , Estados Unidos
7.
Artículo en Inglés | MEDLINE | ID: mdl-21082464

RESUMEN

Pyrrolizidine alkaloids (PAs) are a structurally diverse group of toxicologically relevant secondary plant metabolites. Currently, two analytical methods are used to determine PA content in honey. To achieve reasonably high sensitivity and selectivity, mass spectrometry detection is demanded. One method is an HPLC-ESI-MS-MS approach, the other a sum parameter method utilising HRGC-EI-MS operated in the selected ion monitoring mode (SIM). To date, no fully validated or standardised method exists to measure the PA content in honey. To establish an LC-MS method, several hundred standard pollen analysis results of raw honey were analysed. Possible PA plants were identified and typical commercially available marker PA-N-oxides (PANOs). Three distinct honey sets were analysed with both methods. Set A consisted of pure Echium honey (61-80% Echium pollen). Echium is an attractive bee plant. It is quite common in all temperate zones worldwide and is one of the major reasons for PA contamination in honey. Although only echimidine/echimidine-N-oxide were available as reference for the LC-MS target approach, the results for both analytical techniques matched very well (n = 8; PA content ranging from 311 to 520 µg kg(-1)). The second batch (B) consisted of a set of randomly picked raw honeys, mostly originating from Eupatorium spp. (0-15%), another common PA plant, usually characterised by the occurrence of lycopsamine-type PA. Again, the results showed good consistency in terms of PA-positive samples and quantification results (n = 8; ranging from 0 to 625 µg kg(-1) retronecine equivalents). The last set (C) was obtained by consciously placing beehives in areas with a high abundance of Jacobaea vulgaris (ragwort) from the Veluwe region (the Netherlands). J. vulgaris increasingly invades countrysides in Central Europe, especially areas with reduced farming or sites with natural restorations. Honey from two seasons (2007 and 2008) was sampled. While only trace amounts of ragwort pollen were detected (0-6.3%), in some cases extremely high PA values were detected (n = 31; ranging from 0 to 13019 µg kg(-1), average = 1261 or 76 µg kg(-1) for GC-MS and LC-MS, respectively). Here the results showed significantly different quantification results. The GC-MS sum parameter showed in average higher values (on average differing by a factor 17). The main reason for the discrepancy is most likely the incomplete coverage of the J. vulgaris PA pattern. Major J. vulgaris PAs like jacobine-type PAs or erucifoline/acetylerucifoline were not available as reference compounds for the LC-MS target approach. Based on the direct comparison, both methods are considered from various perspectives and the respective individual strengths and weaknesses for each method are presented in detail.


Asunto(s)
Análisis de los Alimentos/métodos , Miel/análisis , Alcaloides de Pirrolicidina/análisis , Cromatografía Liquida/métodos , Echium/química , Eupatorium/química , Contaminación de Alimentos/análisis , Cromatografía de Gases y Espectrometría de Masas/métodos , Polen/química , Senecio/química , Espectrometría de Masa por Ionización de Electrospray/métodos , Espectrometría de Masas en Tándem/métodos
8.
Methods Inf Med ; 47(6): 549-59, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19020690

RESUMEN

OBJECTIVE: We have been developing a decision support system that uses electronic clinical data and provides alerts to clinicians. However, the inference rules for such a system are difficult to write in terms of representing domain concepts and temporal reasoning. To address this problem, we have developed an ontology-based mediator of clinical information for the decision support system. METHODS: Our approach consists of three steps: 1) development of an ontology-based mediator that represents domain concepts and temporal information; 2) mapping of clinical data to corresponding concepts in the mediator; 3) temporal abstraction that creates high-level, interval-based concepts from time-stamped clinical data. As a result, we can write a concept-based rule expression that is available for use in domain concepts and interval-based temporal information. The proposed approach was applied to a prototype of clinical alert system, and the rules for adverse drug events were executed on data gathered over a 3-month period. RESULTS: The system generated 615 alerts. 346 cases (56%) were considered appropriate and 269 cases (44%) were inappropriate. Of the false alerts, 192 cases were due to data inaccuracy and 77 cases were due to insufficiency of the temporal abstraction. CONCLUSION: Our approach enabled to represent a concept-based rule expression that was available for the prototype of a clinical alert system. We believe our approach will contribute to narrow the gaps of information model between domain concepts and clinical data repositories.


Asunto(s)
Bases de Datos Factuales , Sistemas de Apoyo a Decisiones Clínicas/organización & administración , Técnicas de Apoyo para la Decisión , Internet , Informática Médica/organización & administración , Preparaciones Farmacéuticas , Terminología como Asunto , Acceso a la Información , Formación de Concepto , Sistemas de Administración de Bases de Datos , Bases de Datos como Asunto , Toma de Decisiones Asistida por Computador , Humanos , Japón , Modelos Teóricos , Proyectos Piloto , Diseño de Software
9.
Vet Res Commun ; 31(4): 497-507, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17225086

RESUMEN

Although prevention of feline calcivirus (FCV) infection by vaccination has been attempted, and isolation of FCV, development of the disease, and a few fatal cases in vaccinated cats have been reported. Fifteen FCV strains isolated from cats that had been vaccinated with commercially available FCV vaccines (F9, FCV-255, and FC-7) were genogrouped. Molecular analysis of viral genomes involved the construction of a phylogenetic tree of capsid genes using the NJ method. Cat anti-F9 serum and rabbit anti-FCV-255 serum were used for virus neutralization tests. Molecular phylogenetic analysis of the amino acid sequences of 15 virus isolates and those of the previously published and GenBank-deposited 9 global and 14 Japanese strains showed that 8 (53%) of the 15 virus isolates as well as the vaccine strains F9 and FCV-255 belonged to genogroup I (G(A)I), and 7 (47%) belonged to genogroup II (G(A)II). Of the 8 G(A)I strains, 2 were isolated from cats that had been vaccinated with an F9 strain live vaccine, 5 from cats vaccinated with an FCV-255-derived vaccine, and 1 from a cat vaccinated with an FC-7-derived vaccine. Of the 7 GAll strains, 5 were isolated from cats that had been vaccinated with the F9 strain live vaccine, 1 from a cat vaccinated with the FCV-255-derived vaccine, and 1 from a cat vaccinated with the FC-7-derived vaccine. These results indicate that more vaccine breakdown strains isolated from the cats vaccinated with the F9 strain-derived vaccine belong to G(A)II than to G(A)I, whereas more vaccine breakdown strains isolated from the cats vaccinated with the FCV-255 strain-derived vaccine belong to G(A)I than to G(A)II, and that when the FC-7 strain-derived vaccine is used, the vaccine breakdown strains belong almost equally to G(A)I and G(A)II. Thus, the genogroups of virus isolates varied with the vaccine strain used (p < 0.05). On the other hand, the neutralizing titres of feline anti-F9 serum and rabbit anti-FCV-255 serum against the 15 isolates were very low, showing no relationships between neutralizing antibody titres and genogroups. The DNA sequence identities between the virus isolates and the vaccine strains were low, at 70.6-82.9%, and no strains were found to have sequences derived from the vaccine strains. Alignment of amino acid sequences showed that the G(A)I or G(A)II virus isolates from the F9-vaccinated cats differed at position 428 of the 5' hypervariable region (HVR) of capsid region of the F9 strain, whereas those from the FCV-255-vaccinated cats differed at positions 438, 453, and 460 of the 5'HVR of capsid region E of the F9 strain. We speculate that these differences influence genogrouping. The amino acid changes within the F9 linear epitopes common to G(A)I and G(A)II were noted at positions 450, 451, 457 of 5'HVR of the capsid region E in the isolates from F9-derived vaccine-treated cats, and 449, 450, and 451 of 5'HVR of capsid region E in the isolates from FCV-255-derived vaccine-treated cats, suggesting that these amino acid changes are involved in escapes. These results suggest that alternate vaccination with the F9 and FCV-255 strains or the use of a polyvalent vaccine containing GAll strains serves to inhibit development.


Asunto(s)
Infecciones por Caliciviridae/veterinaria , Calicivirus Felino/genética , Calicivirus Felino/inmunología , Enfermedades de los Gatos/virología , Vacunas Virales/genética , Animales , Infecciones por Caliciviridae/epidemiología , Infecciones por Caliciviridae/prevención & control , Infecciones por Caliciviridae/virología , Calicivirus Felino/clasificación , Enfermedades de los Gatos/epidemiología , Enfermedades de los Gatos/inmunología , Enfermedades de los Gatos/prevención & control , Gatos , Línea Celular , Japón/epidemiología , Vacunas Virales/inmunología
10.
J Hosp Infect ; 65(2): 102-7, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16978732

RESUMEN

Estimating the cost of hospital infection has become a matter of increasing interest in terms of health economics. This study aimed to assess the accuracy of economic studies on hospital infections, using surgical site infection (SSI) as an example. A search was performed for original articles reporting the cost of SSI, published in the English language between 1996 and 2005. For the critical review, the period of cost tracking, classification of costs and cost counting methods were noted. Fifteen articles met the inclusion criteria. The costs of SSI vary according to surgical procedures, country, publication year, study design and accounting method. Only two studies estimated the additional cost of SSI after discharge. All 15 studies included healthcare costs and none measured patient/family resources. In 10 studies, the costs were calculated based on accounting. Three studies used estimated costs from the ratio of costs to charges and two studies used charge data in place of cost data. It will become increasingly important for future studies to perform multi-centre prospective surveys, establish a standard method for cost accounting, include the cost of healthcare services following hospitalization and consider the morbidity cost to patients themselves from a societal perspective.


Asunto(s)
Infección Hospitalaria/economía , Infección de la Herida Quirúrgica/economía , Costos de la Atención en Salud , Humanos
11.
Vet Res Commun ; 30(3): 293-305, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16437305

RESUMEN

We analysed genogroups of four feline calcivirus (FCV) isolates (FCV-S, H10, Ao198-1 and ML89) obtained from cats that experienced FCV infection after having been vaccinated against FCV. New PCR primer sets (8F/8R, Ao-S/Ao-A, cp-S/cp-A) were also designed, since the conventional Seal primer failed to amplify the target sequences in two samples. The genogroups of the four isolates as well as eight global and 17 domestic strains were determined by phylogenetic analysis of their amino acid sequences. One out of the four strains (25%) isolated in this study, H10, was grouped into genogroup I, along with the vaccine strains F9 and FCV-255. The other three isolates (75%) belonged to genogroup II. Thus, there were more isolates in genogroup II than in genogroup I. However, the antibody values of the four isolates against cat anti-F9 antisera were significantly decreased. There may be no relationship between the neutralizing antibody titre and genogroup. Amino acid sequence alignment of the four isolates showed that only a single amino acid in region C, which is involved in neutralization epitopes, was different in ML89 strain from that of F9. The other three strains, H10, Ao198-1 and FCV-B, shared the same amino acid sequence with F9. Alignment of amino acids for linear epitopes in the F9 strain, which are located at regions D and E, showed variations in 5' hypervariable region (HVR) of E, whereas D and conE had only synonymous substitutions i.e. no change in the amino acid sequence. This mutation in 5' HVR of region E suggested a vaccine breakdown, as the region is known to be essential for antigenicity. The genogroup II FCV is likely to be the cause of the FCV infection in this study, while the vaccine strains belong to genogroup I. Thus, the existing vaccine may need reevaluation for its effectiveness.


Asunto(s)
Calicivirus Felino/genética , Calicivirus Felino/aislamiento & purificación , Proteínas de la Cápside/genética , Enfermedades de los Gatos/virología , Vacunas Virales/inmunología , Secuencia de Aminoácidos , Animales , Enfermedades de los Gatos/inmunología , Gatos , Clonación Molecular , ADN Complementario/genética , Datos de Secuencia Molecular , Filogenia , ARN Viral/genética
12.
Vet Res Commun ; 29(6): 517-26, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16215842

RESUMEN

We investigated primitively the molecular basis of the neural spread of a feline calcivirus isolate (FCV-S) from the spinal cord of a cat that died after manifesting excitation. Experimental infections of cats with three clones from parent virus isolate FCV-S, isolated based on plaque size, were performed, and virus recovery from the spinal cord and the nucleotide and predicted amino acid sequences of the viral capsid protein region (ORF2) were compared. In the experimental infection with the one-time cloned virus (C1L1) isolated from a large plaque, the C1L1 was recovered from the spinal cord. In contrast, seven-times cloned C6L7 (from large plaque) and five-times cloned C5S2 (isolated from small plaque) were not recovered from the spinal cord. Genetic analysis of the capsid protein gene of the three viral clones revealed that four bases were different and two amino acids were different at positions 34 (Val in C6L7 and Ala in C1L1 and C5S2) and 46 (Leu in C6L7 and Pro in C1L1 and C5S2) between C6L7 (with large plaque) and C5S2 (with small plaque). The amino acid at position 434 of C1L1 was different from those of C6L7 and C5S2 (Gly in C1L1, D (Asp) in C6L7 and C5S2). From these results, the plaque size seemed not to be related to the spread of virus to the spinal cord. Clone C1L1, which spread to the spinal cord, had a difference of one amino acid from the other two clones, which may be related to the ability to spread to the spinal cord.


Asunto(s)
Infecciones por Caliciviridae/veterinaria , Calicivirus Felino/genética , Proteínas de la Cápside/genética , Enfermedades de los Gatos/virología , Médula Espinal/virología , Secuencia de Aminoácidos , Animales , Infecciones por Caliciviridae/virología , Proteínas de la Cápside/química , Gatos , Secuencia Conservada , Masculino , Distribución Tisular
13.
Vet Rec ; 155(25): 800-5, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15651548

RESUMEN

In June 1993, two of five pet cats kept in Yokohama city in Japan suddenly became agitated and died. Feline calicivirus (FCV) was isolated from them. One strain (FCV-S) was isolated from the spinal cord, lung and tonsil of cat 1, another (FCV-B) from the ileum, medulla oblongata and cervical spinal cord of cat 2, and a third (FCV-SAKURA) from the oral cavity of one of the three surviving cats which showed no clinical signs. These three strains were equally resistant to pH 3.0 and serologically similar to each other, but distinct from strain F9. A genetic analysis, using a 208 base pair fragment from region E of the capsid, showed that FCV-Ari had a 70.4 per cent nucleotide and 77.3 per cent amino acid homology and FCV-F9 had a 68.6 per cent nucleotide and 73.9 per cent amino acid homology with the three strains, indicating that these two strains were genetically distinct from the three new isolates. Unvaccinated cats and cats which had been vaccinated against FCV-F9 developed watery diarrhoea but did not become agitated after the administration of FCV-S. The FCV-S strain did not induce signs of excitability after it was administered orally to specific pathogen-free cats.


Asunto(s)
Infecciones por Caliciviridae/veterinaria , Calicivirus Felino/patogenicidad , Enfermedades de los Gatos/virología , Agitación Psicomotora/virología , Animales , Anticuerpos Antivirales/sangre , Secuencia de Bases , Infecciones por Caliciviridae/virología , Calicivirus Felino/genética , Calicivirus Felino/inmunología , Calicivirus Felino/aislamiento & purificación , Gatos , ADN Viral/química , Brotes de Enfermedades/veterinaria , Resultado Fatal , Masculino , Datos de Secuencia Molecular , Pruebas de Neutralización/veterinaria , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
14.
J Int Med Res ; 31(5): 413-7, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14587309

RESUMEN

Reactive oxygen species are implicated in the pathogenesis of cardiac hypertrophy. Haem oxygenase-1 (HO-1), the rate-limiting enzyme in haem catabolism, is induced by oxidative stress and confers protection against oxidative tissue injuries. We used Northern blotting to examine expression of HO-1 and heat shock protein 70 (HSP70) in the hypertrophic cardiac muscle of eight patients (one infant and seven children) who underwent surgery for congenital heart disease. Levels of HO-1 and HSP70 mRNA were significantly increased in all specimens, but the orders of magnitude of the increases were different, suggesting that the genes expressing HO-1 and HSP70 are regulated separately.


Asunto(s)
Proteínas HSP70 de Choque Térmico/biosíntesis , Cardiopatías/congénito , Ventrículos Cardíacos/enzimología , Hemo Oxigenasa (Desciclizante)/biosíntesis , Antioxidantes/metabolismo , Northern Blotting , Preescolar , Femenino , Hemo-Oxigenasa 1 , Humanos , Lactante , Masculino , Proteínas de la Membrana , Estrés Oxidativo
15.
Vet Rec ; 153(16): 499-501, 2003 Oct 18.
Artículo en Inglés | MEDLINE | ID: mdl-14601797

RESUMEN

Canine distemper virus (CDV) antigen was detected in the serum of dogs by an ELISA and the results of this assay were compared with an anti-CDV immunoglobulin M (IgM) antibody test. In paired sera from 26 naturally infected dogs, the antigen-positive rate was 26.9 per cent at the first examination and 11.5 per cent at the second examination two to three weeks later. The antigen was detected in three of the 10 dogs which were negative for anti-CDV IgM antibody at the first examination. It could also be detected in the serum of between eight and two of 40 specific pathogen-free dogs vaccinated against CDV, for up to four weeks after they were vaccinated.


Asunto(s)
Anticuerpos Antivirales/sangre , Antígenos Virales/sangre , Virus del Moquillo Canino/inmunología , Moquillo/diagnóstico , Ensayo de Inmunoadsorción Enzimática/veterinaria , Animales , Moquillo/sangre , Moquillo/prevención & control , Virus del Moquillo Canino/patogenicidad , Perros , Ensayo de Inmunoadsorción Enzimática/normas , Inmunoglobulina M/sangre , Organismos Libres de Patógenos Específicos , Vacunas Virales
16.
Vet Res Commun ; 26(3): 205-19, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12090292

RESUMEN

The molecular epidemiology of the infectious disease caused by feline calcivirus (FCV) in Japan was investigated by analysing the phylogenetic relationship among 21 Japanese field isolates, including the F4 strain, and 30 global isolates. Parts of the capsid gene (B-F) of the isolates were amplified by RT-PCR, and the amino acid sequences were compared with those from the global isolates. Thirty-seven and 14 out of a total of 51 isolates were clustered into two distinct genogroups, I and II respectively, by UPGMA and NJ analysis. Seven of the 21 Japanese isolates (33%) fell into group I together with 30 global isolates, while the other 14 Japanese isolates (67%) belonged to group II. The bootstrap repetition analysis of groups I and II formed by the NJ method gave a value of 99.00%. The 14 latter Japanese isolates were clearly separated from the isolates in group I, and they were different from any previously known FCV, forming a new genogroup, which implies that this lineage has been confined to Japan. Comparing the amino acid sequences shared by groups I and II, the amino acid at position 377 in B region was asparagine (Asn or Asp (NH2)) in group I, while it was lysine (Lys) in all the strains in group II. Similarly, the amino acid at position 539 in the F region was alanine (Ala) or proline (Pro) in group I, while it was valine (Val) in group II; glycine (Gly) at position 557 in group I was serine (Ser) in Group II; and phenylalanine (Phe) or leucine (Leu) at position 566 in genogroup I was tyrosine (Tyr) in group II.


Asunto(s)
Infecciones por Caliciviridae/veterinaria , Calicivirus Felino/genética , Proteínas de la Cápside/genética , Enfermedades de los Gatos/virología , Secuencia de Aminoácidos , Animales , Anticuerpos Antivirales/farmacología , Secuencia de Bases , Infecciones por Caliciviridae/epidemiología , Infecciones por Caliciviridae/virología , Calicivirus Felino/aislamiento & purificación , Proteínas de la Cápside/química , Enfermedades de los Gatos/epidemiología , Gatos , ADN Complementario/química , ADN Complementario/genética , Japón/epidemiología , Datos de Secuencia Molecular , Pruebas de Neutralización/veterinaria , Filogenia , ARN Viral/química , ARN Viral/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/veterinaria , Alineación de Secuencia , Homología de Secuencia de Aminoácido
17.
Stud Health Technol Inform ; 84(Pt 2): 1359-63, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11604949

RESUMEN

University hospital Medical Information Network (UMIN) was established in 1989 as a collaborative project of national university hospitals in Japan funded by the Ministry of Education, Science, Sports, and Culture, and it started its Internet-based service for medical professionals in 1995. Since then, many services including those for academic societies and research groups have been added. Currently, due to batch registration of the members of large academic societies, the number of registered users and Web accesses are rapidly increasing (about 87,000 registered users and 4,500,000 page views in November, 2000). More than one hundred homepages of academic societies and research groups (including forty- two member-only ones) and one thousand mailing lists are operated. More than one hundred thirty academic societies collect abstracts using the UMIN server. All the Internet-based clinical and epidemiological research projects in Japan are now under way using UMIN. The characteristics of UMIN are its large variety of services and large number of user accounts of medical professionals, which are beneficial to both users and information service providers. UMIN is now important for some medical specialties and will be so for further ones in the future. UMIN is, in fact, evolving into a collaborative project of the Japanese medical community and is considered as its key information infrastructure.


Asunto(s)
Hospitales Universitarios/organización & administración , Servicios de Información , Internet , Servicios de Información/organización & administración , Servicios de Información/estadística & datos numéricos , Japón
18.
J Org Chem ; 66(4): 1455-65, 2001 Feb 23.
Artículo en Inglés | MEDLINE | ID: mdl-11312980

RESUMEN

Palladium(II)-catalyzed oxidative reaction of tert-cyclobutanols involving the cleavage of a C-C bond via beta-carbon elimination under atmospheric pressure of oxygen is described. An alkylpalladium intermediate produced by beta-carbon elimination from a Pd(II) alcoholate gives a variety of products, depending on the substituents on the cyclobutane ring, in which reactions such as dehydrogenative ring opening, ring expansion and ring contraction are involved. For some substrates, the addition of a catalytic amount of ethyl acrylate dramatically accelerates the reaction. In all cases, the dehydrogenative products are obtained and the Pd(II)-hydride species produced at the final stage can be converted again to active Pd(II) species by molecular oxygen.

19.
J Org Chem ; 65(17): 5197-201, 2000 Aug 25.
Artículo en Inglés | MEDLINE | ID: mdl-10993345

RESUMEN

A novel amphiphilic phosphinite-oxazoline chiral compound, 2-methyl-4,5-[4,6-O-benzylidene-3-O-bis[4-((diethylamino)methyl)phenyl]phosphino-1,2-dideoxy-alpha-D-glucopyranosyl]-[2,1-d]-2-oxazoline (1), has been prepared from natural D-glucosamine hydrochloride. The newly prepared complex, [Pd(2-methyl-4,5-[4,6-O-benzylidene-3-O-bis[(4-((diethylmethylammonium)methyl)phenyl)]phosphino-1,2-dideoxy-alpha-D-glucopyranosyl]-[2,1-d]-2-oxazoline)(eta3-C3H5)]3+ x 3BF4- (3), is soluble in water and an efficient catalyst for asymmetric allylic substitution reaction in water or an aqueous/organic biphasic medium (up to 85% ee). This catalytic system offers an easy separation of the aqueous catalyst phase from the product phase and allows recycling of the catalyst phase. In addition, compound 1 also works as an effective ligand for the palladium-catalyzed reaction under conventional homogeneous conditions in an organic medium, in which the catalyst (Pd-1 complex) can be recovered by simple acid/base extraction and reused in the second reaction.

20.
Mol Cell Biol ; 20(13): 4910-21, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10848616

RESUMEN

The DAX-1 (NR0B1) gene encodes an unusual member of the nuclear hormone receptor superfamily which acts as a transcriptional repressor. Mutations in the human DAX-1 gene cause X-linked adrenal hypoplasia congenita (AHC) associated with hypogonadotropic hypogonadism (HHG). We have studied the intracellular localization of the DAX-1 protein in human adrenal cortex and mouse Leydig tumor cells and found it to be both nuclear and cytoplasmic. A significant proportion of DAX-1 is associated with polyribosomes and is found complexed with polyadenylated RNA. DAX-1 directly binds to RNA, two domains within the protein being responsible for cooperative binding activity and specificity. Mutations in DAX-1 found in AHC-HHG patients significantly impair RNA binding. These findings reveal that DAX-1 plays multiple regulatory roles at the transcriptional and posttranscriptional levels.


Asunto(s)
Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Polirribosomas/metabolismo , ARN Mensajero/metabolismo , Proteínas de Unión al ARN/metabolismo , Receptores de Ácido Retinoico/genética , Receptores de Ácido Retinoico/metabolismo , Proteínas Represoras , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Corteza Suprarrenal/metabolismo , Hiperplasia Suprarrenal Congénita/genética , Animales , Sitios de Unión , Línea Celular , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Receptor Nuclear Huérfano DAX-1 , Humanos , Hipogonadismo/genética , Células Intersticiales del Testículo/metabolismo , Células Intersticiales del Testículo/patología , Masculino , Ratones , Mutación , Poli A/metabolismo , Biosíntesis de Proteínas , Proteínas de Unión al ARN/genética , Secuencias Repetitivas de Aminoácido , Ribonucleoproteínas/metabolismo , Ribonucleoproteínas/ultraestructura , Temperatura , Neoplasias Testiculares/metabolismo , Neoplasias Testiculares/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...